Share on StockTwits

Amyris (NASDAQ:AMRS) announced its earnings results on Tuesday. The company reported ($0.26) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.24) by $0.02, StockRatingsNetwork reports.

Amyris (NASDAQ:AMRS) traded down 1.37% during mid-day trading on Tuesday, hitting $3.60. 460,381 shares of the company’s stock traded hands. Amyris has a 52-week low of $2.17 and a 52-week high of $6.11. The stock’s 50-day moving average is $4.13 and its 200-day moving average is $3.11. The company’s market cap is $274.6 million.

On a related note, analysts at Cowen and Company downgraded shares of Amyris from a “market perform” rating to an “underperform” rating in a research note on Thursday, January 2nd. They now have a $3.00 price target on the stock, up previously from $2.40.

Amyris, Inc, formerly Amyris Biotechnologies, Inc develops and provides renewable compounds for a variety of markets.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.